Boundless Bio Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Boundless Bio, Inc. (BOLD) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021
Period EndingDec 2024Dec 2023Dec 2022Dec 2021
Operating Activities
Net Income-65.36-49.43-45.90-25.21
Depreciation & Amortization1.090.960.940.68
Stock Based Compensation7.523.342.291.16
Change in Working Capital-1.68-0.800.87-0.84
Change in Accounts Payable0.781.661.911.22
Change in Other Working Capital-2.45-2.461.700.42
Other Operating Activities2.652.391.700.42
Net Cash from Operating Activities-60.84-46.86-39.60-23.25
Investing Activities
Capital Expenditures-2.54-0.63-1.07-2.03
Purchases of Investments-23.57-37.63-42.60-77.49
Sales/Maturities of Investments184.90122.5059.8020.24
Net Cash from Investing Activities-26.10-38.2616.13-59.29
Financing Activities
Common Stock Issued93.170.180.130.21
Other Financing Activities-3.35-1.960.000.00
Net Cash from Financing Activities89.8297.900.13105.53
Summary
Net Change in Cash2.8812.78-23.3422.99
Cash at Beginning of Period24.2711.4834.8211.83
Cash at End of Period27.1524.2711.4834.82
Free Cash Flow-63.38-47.49-40.66-25.28